-
Loading metrics
Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer
- Sheelagh Frame,
- Chiara Saladino,
- Craig MacKay,
- Butrus Atrash,
- Peter Sheldrake,
- Edward McDonald,
- Paul A. Clarke,
- Paul Workman,
- David Blake,
- Daniella Zheleva
x
- Published: July 9, 2020
- https://doi.org/10.1371/journal.pone.0234103